Amgen (AMGN) Return on Sales [ROS] (2009 - 2026)
Amgen's Return on Sales [ROS] was 34.95% in Q2 2026, up 6.02 percentage points from 28.94% a year earlier and up 4.02 percentage points from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amgen's Return on Sales [ROS] was 29.99% through Jun 30, 2026, up 6.53 percentage points year-over-year; for FY2025, it came in at 24.71%, up 2.99 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of -11.24 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was 21.71% in FY2024 (-6.30 pp), 28.01% in FY2023 (-8.33 pp), 36.34% in FY2022 (+6.94 pp) and 29.40% in FY2021 (-6.54 pp).
- The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] since Q2 2023.
- Compared with a year earlier, Return on Sales [ROS] has increased for seven straight quarters, with an average year-over-year change of +4.88 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q2 2022 (a gain of 20.31 percentage points); the worst was Q1 2024 (a drop of 18.16 percentage points).
- Per Business Quant data, AMGN's Return on Sales [ROS] in the three quarters before Q2 2026 was 30.94% (Q1 2026), 27.57% (Q4 2025) and 26.43% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 32.98% |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 20.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 35.79% |
| Jun 30, 2026 | 34.95% |
| Mar 31, 2026 | 30.94% |
| Dec 31, 2025 | 27.57% |
| Sep 30, 2025 | 26.43% |
| Jun 30, 2025 | 28.94% |
| Mar 31, 2025 | 14.46% |
| Dec 31, 2024 | 25.43% |
| Sep 30, 2024 | 24.07% |
| Jun 30, 2024 | 22.76% |
| Mar 31, 2024 | 13.31% |
| Dec 31, 2023 | 15.51% |
| Sep 30, 2023 | 29.28% |
| Jun 30, 2023 | 38.42% |
| Mar 31, 2023 | 31.47% |
| Dec 31, 2022 | 32.61% |
| Sep 30, 2022 | 39.99% |
| Jun 30, 2022 | 33.00% |
| Mar 31, 2022 | 40.08% |
| Dec 31, 2021 | 33.65% |
API Access
Amgen Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();